Xolair (omalizumab) - Roche, Novartis
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42795912
 
Mirjana Turkalj
 
Sep 27, 2026
 
Prev Next